江西金达莱环保股份有限公司 关于自愿披露对外投资的公告

Investment Overview - The company plans to invest 30 million RMB in Beijing Zhongke Hongtai Medical Technology Co., Ltd., acquiring a 10% stake in the company [1][2] - The investment is part of the company's strategy to optimize its industrial structure and seek new growth opportunities in the medical robotics sector [2] Investment Details - The investment will consist of 195.86895 million RMB for subscribing to the new registered capital and 28.0413105 million RMB to be allocated to capital reserves [2] - The investment has been approved internally and does not require further approval from the board or shareholders [3][4] Target Company Information - Zhongke Hongtai specializes in the research, production, and sales of medical robotics technology and systems, founded by a team of experts from the Chinese Academy of Sciences [5] - The company has over 100 independent intellectual property rights and is involved in significant national projects, including the "14th Five-Year" national key research and development plan [5][6] Product and Market Position - The company's flagship product, a multi-channel vascular interventional surgical robot, has unique advantages such as bionic design and dual-channel operation [6] - The product is currently undergoing clinical trials, with 16 trials completed as of the announcement date [6] Financial and Operational Impact - The investment aims to enhance the company's profitability and overall competitiveness while not affecting its daily operations or financial reporting [16] - The funds will be used exclusively for technology research and development, market promotion, and daily operations, not for debt repayment or unrelated expenditures [12]